SCHEMBL4487525

SCHEMBL4487525

CC(=O)Nc1n[nH]c2cc(-c3ccccc3)ccc12

nearest known ligand 0.73

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 11/20 0.73
GSK3A P49840 3/20 0.70
HDAC6 Q9UBN7 1/20 0.67
FGFR1 P11362 2/20 0.65
FGFR2 P21802 2/20 0.65
FGFR3 P22607 2/20 0.65
DYRK1A Q13627 1/20 0.64
AAK1 Q2M2I8 5/20 0.64
HDAC1 Q13547 1/20 0.63
HDAC2 Q92769 1/20 0.63
HDAC8 Q9BY41 1/20 0.63
PIK3CD O00329 1/20 0.56
PIM1 P11309 1/20 0.56
CDK2 P24941 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4499397 0.89 GSK3B (0.70) GSK3BGSK3AHDAC6FGFR1FGFR2
SCHEMBL4491401 0.88 GSK3B (0.73) GSK3BGSK3AFGFR1FGFR2FGFR3
SCHEMBL4487680 0.85 GSK3B (0.84) GSK3BGSK3AHDAC6HDAC1HDAC2
SCHEMBL4494393 0.85 GSK3B (0.68) GSK3BGSK3AHDAC6FGFR1FGFR2
SCHEMBL4494131 0.85 HDAC6 (0.71) GSK3BHDAC6DYRK1AAAK1HDAC1
SCHEMBL4483349 0.85 GSK3B (0.74) GSK3BGSK3AHDAC6FGFR1FGFR2
SCHEMBL4500909 0.85 HDAC6 (0.70) GSK3BGSK3AHDAC6FGFR1FGFR2
SCHEMBL4499351 0.85 DYRK1A (0.63) GSK3BGSK3AHDAC6FGFR1FGFR2
SCHEMBL4494397 0.85 HDAC6 (0.73) HDAC6FGFR1FGFR2FGFR3DYRK1A
SCHEMBL31060453 0.84 GSK3B (1.00) GSK3BGSK3AHDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632854-B2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2009-12-15 US claimed